The U.S. and Liberian governments have just begun the first formal patient testing of an experimental Ebola virus treatment that's only been used on an emergency basis.
A new vaccine against sexually transmitted human papillomavirus is more effective than the previous version and may protect against 90 percent of all cervical cancers worldwide, researchers said Wednesday.
Floral nectar contains a bouquet of natural chemicals that may help fight parasite infection in bumble bees, a study said Wednesday.
U.S. President Barack Obama on Tuesday called for the United States to lead the way toward a "new era of medicine" by boosting funds for modern medical research.
The first in a new class of cancer medicines, Pfizer's Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe.
An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.
U.S. health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans currently taking them.
The Taiwan Fund for Children and Families (TFCF, 家扶基金會) yesterday published research on disadvantaged children in Taiwan, revealing that ten percent of them have seen illegal drugs, over 40 percent of them cannot afford breakfast every day and 61 percent don't have someone at home to help them with their homework.
The U.S. Food and Drug Administration (FDA) announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the leading U.S. pediatrician's group, which recommends scaling back use of the medicine.